27405584|t|Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI
27405584|a|To evaluate the performance of apparent diffusion coefficient (ADC) and lesion volume in potentially risk - stratifying patients with prostate cancer (PCa). Men with elevated prostate-specific antigen or abnormal digital rectal exam underwent a 3T multiparametric magnetic resonance imaging (mpMRI) with endorectal coil. ADC maps were calculated using b values of 0, 500, 1000, and 1500; additional images were obtained with b value of 2000. We prospectively enrolled 312 men with lesions suspicious for cancer (suspicion score 2-5) on mpMRI. MRI/ultrasound fusion-guided prostate biopsies were performed. Mean ADC of suspicious lesions were correlated against lesion volume, Gleason and D'Amico risk. The cancer detection rate of fusion biopsy per lesion was 45.6% (206/452). Cancerous lesions were larger (median volume: 0.40 vs. 0.30 cm(3); P = 0.016). The median ADC (Ã—10(-6) mm(2) /sec) for lesions negative and positive for PCa were 984.5 and 666.5, respectively (P < 0.0001). The AUC of ADC in predicting PCa was 0.79. Larger lesions were associated with higher risk PCa (Gleason and D'Amico) and lower ADC (all P < 0.0001). The mean ADC of suspicious lesions on mpMRI was inversely correlated, while lesion volume had a direct correlation with PCa detection. Future follow-up studies are needed to assess longitudinal cancer risks of suspicious mpMRI lesions. 2 J. Magn. Reson. Imaging 2017;45:610-616.
27405584	0	4	Risk	T078	C0035647
27405584	5	19	stratification	T062	C1514983
27405584	23	38	prostate cancer	T191	C0376358
27405584	49	79	apparent diffusion coefficient	T077	C3890194
27405584	80	85	value	T081	C1522609
27405584	90	103	lesion volume	T033	C0221198
27405584	107	126	multiparametric MRI	T060	C3898221
27405584	130	138	evaluate	T058	C0220825
27405584	158	188	apparent diffusion coefficient	T077	C3890194
27405584	190	193	ADC	T077	C3890194
27405584	199	212	lesion volume	T033	C0221198
27405584	228	232	risk	T078	C0035647
27405584	235	246	stratifying	T062	C1514983
27405584	247	255	patients	T101	C0030705
27405584	261	276	prostate cancer	T191	C0376358
27405584	278	281	PCa	T191	C0376358
27405584	284	287	Men	T098	C0025266
27405584	293	301	elevated	T080	C3163633
27405584	302	327	prostate-specific antigen	T116,T126,T129	C0138741
27405584	331	359	abnormal digital rectal exam	T060	C1384593
27405584	372	417	3T multiparametric magnetic resonance imaging	T060	C3898221
27405584	419	424	mpMRI	T060	C3898221
27405584	431	446	endorectal coil	T074	C0025080
27405584	448	451	ADC	T077	C3890194
27405584	452	456	maps	T170	C0282574
27405584	526	532	images	T170	C1704254
27405584	599	602	men	T098	C0025266
27405584	608	615	lesions	T033	C0221198
27405584	616	626	suspicious	T078	C0750493
27405584	631	637	cancer	T191	C0006826
27405584	639	654	suspicion score	T081	C0449820
27405584	663	668	mpMRI	T060	C3898221
27405584	670	716	MRI/ultrasound fusion-guided prostate biopsies	T060	C3898501
27405584	738	741	ADC	T077	C3890194
27405584	745	755	suspicious	T078	C0750493
27405584	756	763	lesions	T033	C0221198
27405584	788	801	lesion volume	T033	C0221198
27405584	803	827	Gleason and D'Amico risk	T185	C0008902
27405584	833	839	cancer	T191	C0006826
27405584	840	854	detection rate	T081	C1265611
27405584	858	871	fusion biopsy	T060	C3898501
27405584	876	882	lesion	T033	C0221198
27405584	904	913	Cancerous	T191	C0006826
27405584	914	921	lesions	T033	C0221198
27405584	994	997	ADC	T077	C3890194
27405584	1023	1030	lesions	T033	C0221198
27405584	1031	1052	negative and positive	T033	C3842923
27405584	1057	1060	PCa	T191	C0376358
27405584	1114	1117	AUC	T081	C0376690
27405584	1121	1124	ADC	T077	C3890194
27405584	1139	1142	PCa	T191	C0376358
27405584	1160	1167	lesions	T033	C0221198
27405584	1173	1188	associated with	T080	C0332281
27405584	1189	1200	higher risk	T033	C0332167
27405584	1201	1204	PCa	T191	C0376358
27405584	1206	1225	Gleason and D'Amico	T185	C0008902
27405584	1231	1240	lower ADC	T033	C3810244
27405584	1268	1271	ADC	T077	C3890194
27405584	1275	1285	suspicious	T078	C0750493
27405584	1286	1293	lesions	T033	C0221198
27405584	1297	1302	mpMRI	T060	C3898221
27405584	1335	1348	lesion volume	T033	C0221198
27405584	1362	1373	correlation	T080	C1707520
27405584	1379	1382	PCa	T191	C0376358
27405584	1383	1392	detection	T033	C0442726
27405584	1401	1418	follow-up studies	T062	C0016441
27405584	1440	1459	longitudinal cancer	T191	C0006826
27405584	1460	1465	risks	T078	C0035647
27405584	1469	1479	suspicious	T078	C0750493
27405584	1480	1485	mpMRI	T060	C3898221
27405584	1486	1493	lesions	T033	C0221198